You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
SLE, Sjögren’s and APS - treatment
THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wallace DJ, Ordi-Ros J, Neuwelt M, et al
THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)
Annals of the Rheumatic Diseases 2013;72:A259.